ULTRARUN Trademark

Trademark Overview


On Tuesday, October 15, 2019, a trademark application was filed for ULTRARUN with the United States Patent and Trademark Office. The USPTO has given the ULTRARUN trademark a serial number of 79274572. The federal status of this trademark filing is REGISTERED as of Tuesday, August 11, 2020. This trademark is owned by Qiagen GmbH. The ULTRARUN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical, biochemical and biotechnological diagnostic preparations used in science; non-medical reagents, enzymes and chemicals, namely, buffer solutions, used in analytical chemistry, for scientific and medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning

Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning f...
ultrarun

General Information


Serial Number79274572
Word MarkULTRARUN
Filing DateTuesday, October 15, 2019
Status700 - REGISTERED
Status DateTuesday, August 11, 2020
Registration Number6121360
Registration DateTuesday, August 11, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements


Goods and ServicesChemical, biochemical and biotechnological diagnostic preparations used in science; non-medical reagents, enzymes and chemicals, namely, buffer solutions, used in analytical chemistry, for scientific and medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning
Goods and ServicesDiagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes
Pseudo MarkULTRA RUN

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, December 23, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQiagen GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameQiagen GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameQiagen GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Saturday, December 26, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 4, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 4, 2020FINAL DISPOSITION PROCESSED
Wednesday, November 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 11, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 25, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 13, 2020REFUSAL PROCESSED BY IB
Friday, February 21, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 21, 2020REFUSAL PROCESSED BY MPU
Wednesday, January 29, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 28, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 21, 2020ASSIGNED TO EXAMINER
Friday, December 27, 2019APPLICATION FILING RECEIPT MAILED
Monday, December 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 19, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB